
Nikki Lynn Neubauer MD
Gynecologic Oncology
Assistant Professor in Obstetrics and Gynecology
Join to view full profile
3825 Highland Ave.Suite 307Downers Grove, IL 60515
Phone+1 708-422-3242
Fax+1 708-422-3243
Dr. Neubauer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Gynecologic Oncology, 2009 - 2012
Duke University HospitalResidency, Obstetrics and Gynecology, 2005 - 2009
Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
IL State Medical License 2009 - 2029
NC State Medical License 2005 - 2009
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013-2015, 2017
Clinical Trials
- Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
- Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2013 Jun 06
Publications & Presentations
PubMed
- 5 citationsTiming and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros
European Journal of Gynaecological Oncology. 2023-02-01 - 7 citationsEfficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trialMathew Cowan, Wendy M. Swetzig, Valery Adorno-Cruz, Mario Javier Pineda, Nikki L. Neubauer
Gynecologic Oncology. 2021-10-01 - 26 citationsA Comparison of Survival and Recurrence Outcomes in Patients With Endometrial Cancer Undergoing Robotic Versus Open SurgeryHyo K. Park, Irene Helenowski, Emily Berry, John R. Lurain, Nikki L. Neubauer
Journal of Minimally Invasive Gynecology. 2015-09-01
Press Mentions
Ovarian Cancer Warning SignsFebruary 4th, 2019
Know the Warning Signs for Ovarian CancerMarch 2nd, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









